Xiao-Xu-Ming decoction prevented hemorrhagic transformation induced by acute hyperglycemia through inhibiting AGE-RAGE-mediated neuroinflammation
- PMID: 33964468
- DOI: 10.1016/j.phrs.2021.105650
Xiao-Xu-Ming decoction prevented hemorrhagic transformation induced by acute hyperglycemia through inhibiting AGE-RAGE-mediated neuroinflammation
Abstract
Stroke is one of the leading causes of death worldwide. Hemorrhagic transformation (HT) is a common serious complication of ischemic stroke (IS) and is related to poor prognosis. Hyperglycemia after stroke is associated with the occurrence of HT and seriously affects the clinical treatment of stroke. Our previous experiments demonstrated that the Xiao-Xu-Ming decoction effective components group (XXMD), which is a Chinese medicine formula reconstituted by active ingredients, has multiple pharmacological effects in the treatment of IS. However, the effects of XXMD on HT after IS remain unclear. Thus, we investigated the preventive effects of XXMD on hyperglycemia-induced HT and further explored the underlying mechanism. Acute hyperglycemia combined with the electrocoagulation cerebral ischemia model was used to establish the HT model. XXMD (37.5, 75, 150 mg/kg/d) was given by gavage for 5 days. Network pharmacology was used to predict potential targets and pathways of XXMD in HT occurrence, and further studies confirmed the related targets. The results showed that hyperglycemia aggravated neurological deficits and blood-brain barrier (BBB) disruption, leading to intracerebral hemorrhage. Pretreatment with XXMD improved neurological function and BBB integrity and inhibited HT occurrence. Network pharmacology revealed that AGE-RAGE-mediated neuroinflammation may be associated with hyperglycemia-induced HT. Further studies confirmed that hyperglycemia activated the AGE-RAGE signaling pathway, increased the expression of HMGB1, TLR4 and p-p65, and induced the release of inflammatory factors and neutrophil infiltration, leading to HT. XXMD could inhibit AGE-RAGE-mediated neuroinflammation. These findings indicated that pretreatment with XXMD alleviated hyperglycemia-induced HT, which may be associated with the inhibition of AGE-RAGE-mediated neuroinflammation. Therefore, XXMD may be a potential therapeutic drug for HT.
Keywords: AGE-RAGE; Blood-brain barrier; Hemorrhagic transformation; Hyperglycemia; Ischemic stroke; Xiao-Xu-Ming decoction.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
-
Xiaoxuming decoction enhanced neuroprotection after cerebral ischemia/reperfusion via the JAK2/STAT3 signaling pathway based on UPLC/HRMS, network pharmacology and experimental validation.J Ethnopharmacol. 2025 Jan 31;340:119279. doi: 10.1016/j.jep.2024.119279. Epub 2024 Dec 24. J Ethnopharmacol. 2025. PMID: 39725365
-
Pharmacokinetics of 21 active components in focal cerebral ischemic rats after oral administration of the active fraction of Xiao-Xu-Ming decoction.J Pharm Biomed Anal. 2016 Apr 15;122:110-7. doi: 10.1016/j.jpba.2016.01.052. Epub 2016 Feb 4. J Pharm Biomed Anal. 2016. PMID: 26852160
-
Xiao-Xu-Ming decoction preserves mitochondrial integrity and reduces apoptosis after focal cerebral ischemia and reperfusion via the mitochondrial p53 pathway.J Ethnopharmacol. 2014;151(1):307-16. doi: 10.1016/j.jep.2013.10.042. Epub 2013 Nov 1. J Ethnopharmacol. 2014. PMID: 24189031
-
A Network Pharmacology-Based Identification Study on the Mechanism of Xiao-Xu-Ming Decoction for Cerebral Ischemic Stroke.Evid Based Complement Alternat Med. 2020 Oct 19;2020:2507074. doi: 10.1155/2020/2507074. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33133212 Free PMC article. Review.
-
Hemorrhagic transformation after ischemic stroke in animals and humans.J Cereb Blood Flow Metab. 2014 Feb;34(2):185-99. doi: 10.1038/jcbfm.2013.203. Epub 2013 Nov 27. J Cereb Blood Flow Metab. 2014. PMID: 24281743 Free PMC article. Review.
Cited by
-
Combination of Systems Pharmacology and Experimental Evaluation to Explore the Mechanism of Synergistic Action of Frankincense-Myrrh in the Treatment of Cerebrovascular Diseases.Front Pharmacol. 2022 Jan 10;12:796224. doi: 10.3389/fphar.2021.796224. eCollection 2021. Front Pharmacol. 2022. PMID: 35082676 Free PMC article.
-
Brain and serum metabolomic studies reveal therapeutic effects of san hua decoction in rats with ischemic stroke.Front Endocrinol (Lausanne). 2023 Nov 30;14:1289558. doi: 10.3389/fendo.2023.1289558. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38098862 Free PMC article.
-
Influence of glycated hemoglobin on thromboinflammation in acute ischemic stroke: a retrospective, propensity score matching study.Front Endocrinol (Lausanne). 2025 Jul 28;16:1542549. doi: 10.3389/fendo.2025.1542549. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40791995 Free PMC article.
-
Novel Insight into the Modulatory Effect of Traditional Chinese Medicine on Cerebral Ischemia-Reperfusion Injury by Targeting Gut Microbiota: A Review.Drug Des Devel Ther. 2025 Jan 10;19:185-200. doi: 10.2147/DDDT.S500505. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 39810832 Free PMC article. Review.
-
Comparative Effects of Glenzocimab and Eptifibatide on Bleeding Severity in 2 Mouse Models of Intracranial Hemorrhage.J Am Heart Assoc. 2025 Feb 4;14(3):e034207. doi: 10.1161/JAHA.123.034207. Epub 2025 Jan 17. J Am Heart Assoc. 2025. PMID: 39818980 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical